Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Tsutomu Ryoke"'
Autor:
Noboru Watanabe, Osamu Yokoseki, Minoru Hongo, Toshishige Shibamoto, Tsutomu Ryoke, Mafumi Owa, Eiji Hironaka
Publikováno v:
Cardiovascular Drugs and Therapy. 15:241-249
Growth hormone (GH) has been attracted as a possible adjunctive treatment for severe heart failure. However, its treatment effects have been still controversial. To assess severity of basal cardiac disease states in which GH might be effective, we an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07ecab1a9736c1cd921d6f47948816e6
https://doi.org/10.1023/a:1011968323620
https://doi.org/10.1023/a:1011968323620
Autor:
Hiroyuki Kakukawa, Yuko Nishimura, Takashi Fujii, Tsutomu Ryoke, Masunori Matsuzaki, Hisanori Sakai, Yoshihide Minami, Hideki Kunichika
Publikováno v:
Japanese Circulation Journal. 64:389-392
A patient with subacute pericarditis showed no evidence suggesting tuberculosis until pericardiectomy was performed because of hemodynamic deterioration. The excised pericardium had a rubbery fibroelastic consistency; histologically, there were granu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276a5097f62a0c4d2a19a153c9825bec
https://doi.org/10.1253/jcj.64.389
https://doi.org/10.1253/jcj.64.389
Publikováno v:
Circulation. 100:1734-1743
Background —Growth hormone (GH) improves cardiac function in the rat with myocardial infarction, but its effects in a model of primary dilated cardiomyopathy have not been reported. GH effects were examined at early (4 months) and late (10 months)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621ec87ca3581c5561c1f9061c816e3f
https://doi.org/10.1161/01.cir.100.16.1734
https://doi.org/10.1161/01.cir.100.16.1734
Autor:
John Ross, Tsutomu Ryoke, Howard A. Rockman, Lan Mao, Minoru Hongo, Nobuaki Tanaka, Ross G. Clark
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 275:H393-H399
Cardiac hypertrophic and contractile responses were studied in mice administered growth hormone (GH) and insulin-like growth factor (IGF-I) (8 mg ⋅ kg−1⋅ day−1), alone or in combination (IGF-I/GH), for 2 wk. Also, changes in expression of sel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e37c9f5ceedc082925e73fc24c3b7fd5
https://doi.org/10.1152/ajpheart.1998.275.2.h393
https://doi.org/10.1152/ajpheart.1998.275.2.h393
Publikováno v:
Trends in Cardiovascular Medicine. 7:161-167
Heart failure is a complex syndrome characterized by inability of the heart to supply sufficient cardiac output to meet the metabolic needs of the body. Over the past few decades, a number of animal models of heart failure have been developed to stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da9ef124a9654b2ff4728fb6292a2e86
https://doi.org/10.1016/s1050-1738(97)00029-7
https://doi.org/10.1016/s1050-1738(97)00029-7
Autor:
Yuji Hisamatsu, Tomoko Ohkusa, Tsutomu Ryoke, Masafumi Yano, Masakazu Obayashi, Masunori Matsuzaki, Shigeki Kobayashi, Katsutoshi Yamakawa, Michihiro Kohno
Publikováno v:
Circulation. 94:3362-3368
Background Aortic input impedance, which represents LV afterload, is considered to be a major determinant for the development of pressure-overload left ventricular (LV) hypertrophy. Methods and Results To test whether the sustained change in aortic i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4a487e78061b35ca7e0bd5cde687bc
https://doi.org/10.1161/01.cir.94.12.3362
https://doi.org/10.1161/01.cir.94.12.3362
Autor:
Masahiko Harada, Tsutomu Ryoke, Hiroshi Ogawa, Akihisa Fujii, Kaoru Ono, Tatsunori Itagaki, Seiji Umemoto, Akira Takaki, Masunori Matsuzaki, Takahito Yonezawa, Kouzaburo Seki, Masakazu Tanaka
Publikováno v:
Journal of atherosclerosis and thrombosis. 18(10)
AIM: We examined the anti-oxidant mechanisms of combined therapy of eicosapentaenoic acid (EPA) plus statin on the progression of atherosclerosis. METHODS: Patients receiving statin therapy for dyslipidemia and with coronary artery disease (CAD) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c338440921a6f13ede85357afe5da828
https://pubmed.ncbi.nlm.nih.gov/21701083
https://pubmed.ncbi.nlm.nih.gov/21701083
Autor:
Eun-Seok Jeon, Yusu Gu, Sam S. Oh, Yasuhiro Ikeda, Maryann E. Martone, Tsutomu Ryoke, Kirk U. Knowlton, John Ross
Publikováno v:
Basic research in cardiology. 97(1)
The genetic defect in the cardiomyopathic (CM) hamster is a mutation in the glycoprotein-sarcoglycan (a component of the dystrophin-glycoprotein complex). Apoptosis has been identified in skeletal muscle of dystrophin-deficient mice, and therefore th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acef609e8c015f5846414759aba87e96
https://pubmed.ncbi.nlm.nih.gov/12004790
https://pubmed.ncbi.nlm.nih.gov/12004790
Autor:
David G. Lowe, Kenneth R. Chien, John Ross, John J. Hunter, Ross G. Clark, Minoru Hongo, Jill Schoenfeld, Tsutomu Ryoke, Nancy D. Dalton
Publikováno v:
Basic research in cardiology. 95(6)
Beneficial cardiac effects of growth hormone (GH) have been shown in heart failure in several settings, but studies are lacking on this and other forms of treatment in the cardiomyopathic (CM) mouse heart. In mice with dilated cardiomyopathy due to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec2c75f77e82635e122f65de991194f
https://pubmed.ncbi.nlm.nih.gov/11192363
https://pubmed.ncbi.nlm.nih.gov/11192363
Publikováno v:
Journal of cardiovascular pharmacology. 31(2)
To assess the effects of celiprolol, which is a selective beta1-antagonist with vasodilating properties, on chronic heart failure in the cardiomyopathic hamster UM-X7.1 (CMH), we studied survival in treated CMH (celiprolol, 100 mg/kg/day) and untreat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09de1fe09e334d444229c7e72aec719
https://pubmed.ncbi.nlm.nih.gov/9475257
https://pubmed.ncbi.nlm.nih.gov/9475257